Delivery Order SPE2DB20D1051-SPE2DB23FD8VV
Award Date 8/4/23
Potential Completion Date 8/7/23
Potential Value $1.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,756.20 delivery order contract to Amerisourcebergen Drug Corporation for 4561738025 meningococcal group quadrivalent (MenQuadFI) vaccine vials. As the prime contractor, Amerisourcebergen will deliver 0.5 milliliter MenQuadFI vials to support the Department of Defense. The firm fixed price order is for performance from August 8 to August 9, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $45,041.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562224126 doses of MENQUADFI vaccine vials. As the prime contractor, Amerisourcebergen will deliver the 0.5ml vials to its Conshohocken, Pennsylvania facility by September 20, 2023 to support the Department of Defense's stockpiling and distribution of meningococcal vaccines. No subcontractors or set aside designations were identified. This order is likely placed against...
- The Defense Logistics Agency awarded a $7,303 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561836468 MENQUADFI VIAL 0.5ML. As a major pharmaceutical supplier, Amerisourcebergen will deliver the meningococcal vaccine vials to a location in Conshohocken, Pennsylvania by August 17, 2023 to support the Department of Defense's immunization programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency awarded a $6,322.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561523649 MENQUADFI vials. As the prime contractor, Amerisourcebergen will supply 0.5ml vials of the meningococcal vaccine to support the Department of Defense's immunization programs. The single day period of performance indicates this was likely an urgent order to replenish vaccine inventory. Amerisourcebergen will fulfill the contract from its facility in Conshohocken,...
- The Defense Logistics Agency awarded a $14,629.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561758962 doses of MENQUADFI vaccine vials. As the prime contractor, Amerisourcebergen will deliver the 0.5ml vials to its Conshohocken, Pennsylvania facility by August 10, 2023 to support the Department of Defense's stockpiling and distribution of the meningococcal vaccines through its prime vendor program. No subcontractors or set aside designations were identified in...
- The Defense Logistics Agency awarded a delivery order valued at approximately $3,161 to Amerisourcebergen Drug Corporation for 4561804552 MENQUADFI vials. As the prime contractor, Amerisourcebergen will supply 0.5ml vials of the meningococcal vaccine to the Defense Logistics Agency for use in its immunization programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from August 14 to August 15, 2023. The contract utilizes a firm...
- The Defense Logistics Agency awarded a $1,405 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561530904 MENQUADFI VIAL 0.5ML. As the prime contractor, Amerisourcebergen will deliver the meningococcal vaccine vials to a location in Conshohocken, Pennsylvania by July 19, 2023 in support of Department of Defense immunization programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle to...
- The Defense Logistics Agency awarded a $40,403 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562061586 MENQUADFI vials. As the prime contractor, Amerisourcebergen will supply 0.5ml vials of the meningococcal vaccine to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania. Performance is required from September 6 to 7, 2023. The delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle, though...
- The Defense Logistics Agency awarded a $47,137 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561354972 MENQUADFI VIAL 0.5ML. As a major pharmaceutical distributor, Amerisourcebergen will deliver meningococcal vaccines to support the Department of Defense's immunization programs. The delivery order was issued against an existing DLA pharmaceutical distribution contract vehicle. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania within...
- The Defense Logistics Agency awarded a $4,425 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561949325 MENQUADFI VIAL 0.5ML. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the meningococcal vaccines to a facility in Conshohocken, Pennsylvania by August 28, 2023 under the terms of the award. No set aside designation or subcontractors were identified. The delivery order was issued against an...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB23FD8VVDelivery Order
The Defense Logistics Agency awarded a $1,756.20 delivery order contract to Amerisourcebergen Drug Corporation for 4561704329 MENQUADFI vial doses of 0.5ml each. As the prime contractor, Amerisourcebergen will deliver the meningococcal vaccine vials to a location in Conshohocken, Pennsylvania by August 7, 2023 to support the Department of Defense's immunization programs. The firm fixed price contract was awarded under DLA's Pharmaceutical Prime Vendor contract vehicle and does not contain any set aside provisions. Amerisourcebergen, operating through its Amerisourcebergen Corporation division, will likely fulfill the order using its extensive distribution network without the involvement of major subcontractors.
Generated 12/23/23, 1:29 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/4/23 |